Drug recall · December 27, 2017
Amethyst recall
Why: Labeling: Incorrect Instructions. "TABLETS IN WEEK 4 ARE INACTIVE" printed on the blister foil and package insert, however,all tablets are active.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Amethyst (Levonorgestrel and Ethinyl Estradiol Tablets USP, 90mcg/20mcg), 28 tablet dispenser (blister foil unit), Rx only, Manufactured by: Warner Chilcott Company, LLC Fajardo, Puerto Rico 00738: Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054 USA, NDC-52544-295-28
- Lots / codes
Lot # 544637A
- Quantity
- 5,374 blister cards/28 tablets
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Nationwide in the USA and Puerto Rico
- Initiated
- November 20, 2017 · Voluntary: Firm initiated
- Classified
- December 20, 2017
- Reported
- December 27, 2017
- Ended
- June 21, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Estradiol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.